메뉴 건너뛰기




Volumn 11, Issue 5, 2001, Pages 296-301

Solid malignant uterine tumours

Author keywords

Endometrial stromal sarcomas; Leiomyosarcomas; Mixed mesodermal sarcomas; Uterus

Indexed keywords

DOXORUBICIN; IFOSFAMIDE;

EID: 0035170510     PISSN: 09575847     EISSN: None     Source Type: Journal    
DOI: 10.1054/cuog.2001.0199     Document Type: Conference Paper
Times cited : (8)

References (23)
  • 5
    • 0026635993 scopus 로고
    • Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: The result of a retrospective study of 423 cases of uterine sarcoma
    • (1992) Br J Obstet Gynaecol , vol.99 , Issue.7 , pp. 590-594
    • Olah, K.S.1    Dunn, J.A.2    Gee, H.3
  • 17
    • 0029867758 scopus 로고    scopus 로고
    • Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: A study of the Gynecologic Oncology Group
    • (1996) Obstet Gynecol , vol.87 , Issue.5 PART 1 , pp. 747-750
    • Sutton, G.1    Blessing, J.A.2    Park, R.3
  • 19
    • 85031479683 scopus 로고    scopus 로고
    • Gynecologic Oncology Group: Phase III Study of IFF and the Uroprotector Mesna Administered Alone or with CDDP in Patients with Advanced or Recurrent Mixed Mesodermal Tumors of the Uterus (Summary Last Modified 08/95), GOG-108, clinical trial, closed, 07/29
    • (1996)
    • Sutton, G.P.1
  • 20
  • 21
    • 0021923477 scopus 로고
    • Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of Gynecologic Oncology Group)
    • (1985) Cancer , vol.55 , Issue.8 , pp. 1648-1653
    • Muss, H.B.1    Bundy, B.2    DiSaia, P.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.